Results
61
Gain exposure to companies in the healthcare sector with a strong future outlook and robust financials.
61 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
0NES | €0.91 | -0.3% | -0.8% | €169.8m | €1.05 | PB1.1x | E78.0% | 7.7% | ||
0DYQ | €12.75 | 0.8% | -30.1% | €168.9m | €17.24 | PE83.8x | E50.0% | n/a | ||
0H8I | US$1.84 | 3.8% | -32.8% | US$179.5m | US$6.28 | PB4x | E130.6% | n/a | ||
CREO | UK£0.27 | -5.3% | -15.1% | UK£94.1m | n/a | PS3.1x | E78.5% | n/a | ||
0R44 | SEK 37.35 | 2.9% | 27.0% | SEK 1.3b | SEK 56.77 | PE23.5x | E33.9% | n/a | ||
CRADBS | SEK 45.95 | 0% | n/a | SEK 1.1b | SEK 95.73 | PE93x | E49.0% | n/a | ||
0H9M | NOK 14.33 | 0% | -9.1% | NOK 1.2b | NOK 23.80 | PS4.5x | E112.6% | 11.5% | ||
SPEC | UK£0.51 | -1.9% | -41.8% | UK£51.9m | n/a | PB0.5x | E118.5% | 0% | ||
IMMNOS | SEK 34.30 | 0% | -44.7% | SEK 551.8m | SEK 119.59 | PS581.4x | E76.7% | n/a | ||
QLINES | SEK 4.78 | 0% | -81.0% | SEK 380.9m | SEK 14.66 | PS60.2x | E57.4% | n/a | ||
0IFR | US$1.24 | 0% | 75.5% | US$25.9m | US$6.46 | PS1.4x | E71.2% | n/a | ||
0I0L | €4.11 | 0% | n/a | €15.5m | €3.10 | PB0.4x | E133.9% | 0% | ||
RUA | UK£0.12 | -2.0% | -23.8% | UK£7.4m | n/a | PS3.4x | E98.2% | n/a |